Carcinogenesis, Vol. 20, No. 9, 1747-1753,
September 1999
© 1999 Oxford University Press
Carcinogenesis |
Induction of melanoma in TPras transgenic mice
Arizona Cancer Center, University of Arizona, 1515 North Campbell Avenue, PO Box 245042, Tucson, AZ 85724-5024, USA
In order to study the oncogenesis of melanocytes, transgenic mouse lines were established that express a mutated human Ha-ras (TPras) gene in pigment producing cells. The ras transgenic mice exhibit an altered phenotype, including melanocytic hyperplasia and a muted agouti coat, indicative of hyperproliferative melanocytes. These mice and their wild-type littermates have been subjected to a variety of carcinogenesis protocols, including 7,12-dimethylbenz-[a]anthracene (DMBA), 12-O-tetradecanoylphorbol-13-acetate (TPA) and UV radiation exposure. Topical DMBA treatment of TPras mice resulted in a high incidence of melanomas. Metastatic lesions were observed in skin, lungs and lymph nodes. TPA treatment of TPras mice induced a small number of papillomas but no nevi or melanomas. UV light exposures induced papillomas in negative littermate and melanomas in some albino TPras mice. These results show that melanocytes expressing an activated Ha-ras in the TPras transgenic mice are susceptible to induction of melanoma by DMBA.
Abbreviations: DMBA, 7,12-dimethylbenz[a]anthracene; SCID, severe combined immunodeficient; TPA, 12-O-tetradecanoylphorbol-13-acetate.
1 To whom correspondence should be addressed Email: mbroome{at}azcc.arizona.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Chakravarti, R. Lotan, A. H. Diwan, C. L. Warneke, M. M. Johnson, and V. G. Prieto Decreased Expression of Retinoid Receptors in Melanoma: Entailment in Tumorigenesis and Prognosis Clin. Cancer Res., August 15, 2007; 13(16): 4817 - 4824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bedogni, S. M. Welford, A. C. Kwan, J. Ranger-Moore, K. Saboda, and M. B. Powell Inhibition of phosphatidylinositol-3-kinase and mitogen-activated protein kinase kinase 1/2 prevents melanoma development and promotes melanoma regression in the transgenic TPRas mouse model Mol. Cancer Ther., December 1, 2006; 5(12): 3071 - 3077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tormo, A. Ferrer, E. Gaffal, J. Wenzel, E. Basner-Tschakarjan, J. Steitz, L. C. Heukamp, I. Gutgemann, R. Buettner, M. Malumbres, et al. Rapid Growth of Invasive Metastatic Melanoma in Carcinogen-Treated Hepatocyte Growth Factor/Scatter Factor-Transgenic Mice Carrying an Oncogenic CDK4 Mutation Am. J. Pathol., August 1, 2006; 169(2): 665 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Hacker, H. K. Muller, N. Irwin, B. Gabrielli, D. Lincoln, S. Pavey, M. B. Powell, M. Malumbres, M. Barbacid, N. Hayward, et al. Spontaneous and UV Radiation-Induced Multiple Metastatic Melanomas in Cdk4R24C/R24C/TPras Mice. Cancer Res., March 15, 2006; 66(6): 2946 - 2952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. van Schanke, G. M.C.A.L. van Venrooij, M. J. Jongsma, H. A. Banus, L. H.F. Mullenders, H. J. van Kranen, and F. R. de Gruijl Induction of Nevi and Skin Tumors in Ink4a/Arf Xpa Knockout Mice by Neonatal, Intermittent, or Chronic UVB Exposures. Cancer Res., March 1, 2006; 66(5): 2608 - 2615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ackermann, M. Frutschi, K. Kaloulis, T. McKee, A. Trumpp, and F. Beermann Metastasizing Melanoma Formation Caused by Expression of Activated N-RasQ61K on an INK4a-Deficient Background Cancer Res., May 15, 2005; 65(10): 4005 - 4011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bedogni, M. S. O'Neill, S. M. Welford, D. M. Bouley, A. J. Giaccia, N. C. Denko, and M. B. Powell Topical Treatment with Inhibitors of the Phosphatidylinositol 3'-Kinase/Akt and Raf/Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Pathways Reduces Melanoma Development in Severe Combined Immunodeficient Mice Cancer Res., April 1, 2004; 64(7): 2552 - 2560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Fitch, K. A. McGowan, C. D. van Raamsdonk, H. Fuchs, D. Lee, A. Puech, Y. Herault, D. W. Threadgill, M. H. de Angelis, and G. S. Barsh Genetics of dark skin in mice Genes & Dev., January 15, 2003; 17(2): 214 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Recio, F. P. Noonan, H. Takayama, M. R. Anver, P. Duray, W. L. Rush, G. Lindner, E. C. De Fabo, R. A. DePinho, and G. Merlino Ink4a/Arf Deficiency Promotes Ultraviolet Radiation-induced Melanomagenesis Cancer Res., November 15, 2002; 62(22): 6724 - 6730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lluria-Prevatt, J. Morreale, J. Gregus, D. S. Alberts, F. Kaper, A. Giaccia, and M. B. Powell Effects of Perillyl Alcohol on Melanoma in the TPras Mouse Model Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 573 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P. Noonan, T. Otsuka, S. Bang, M. R. Anver, and G. Merlino Accelerated Ultraviolet Radiation-induced Carcinogenesis in Hepatocyte Growth Factor/Scatter Factor Transgenic Mice Cancer Res., July 1, 2000; 60(14): 3738 - 3743. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Wang and A. Richmond Nuclear Factor-kappa B Activation by the CXC Chemokine Melanoma Growth-stimulatory Activity/Growth-regulated Protein Involves the MEKK1/p38 Mitogen-activated Protein Kinase Pathway J. Biol. Chem., January 26, 2001; 276(5): 3650 - 3659. [Abstract] [Full Text] [PDF]
|
|